Groupe Bastide Strengthening Itself in Strategic Areas With New Acquisitions in France
05 Janeiro 2022 - 3:22PM
Business Wire
Regulatory News:
Bastide Le Confort Médical (Euronext Paris Compartment B:
BLC, FR0000035370), a
specialist in home healthcare services, announces that it has
carried out acquisitions in a number of strategic areas in France.
With strengthened financial leeway following its recent refinancing
operation, the Group has resumed an active external growth policy
in order to increase the digital part of its activity and its
business volume in its more value-added activities.
Acquisition of a leader in the online distribution of medical
equipment and a start-up specialized in connecting health
professionals
Groupe Bastide has acquired Distrimed, the French number 2 in
online sales of medical equipment for health professionals. This
digital player recorded revenue of €12.3 million in 2020 and
delivers profitability that exceeds the Group’s standards.
Distrimed will be consolidated in Groupe Bastide’s accounts from
December 1, 2021. At the same time, the Groupe Bastide has also
acquired Care Service, which provides innovative digital solutions
for connecting health professionals. Care Service, which does not
yet generate any revenue, will also be consolidated in the Group’s
accounts from December 1, 2021. Through these two operations,
Groupe Bastide is reaffirming its ambition to become a major player
in the online sale of medical equipment in order to enhance its
profitability in a healthcare market where the move towards digital
is a growing and long-term trend further accentuated by the current
health context.
Acquisition of a regional player to strengthen its nationwide
coverage in perfusion
On January 4, Bastide finalized the acquisition of the entire
share capital of Saad Perfusion, a perfusion specialist located in
the Grand-Est region of France where it recorded revenue of €0.7
million in 2020 and generated a higher margin than the Group.
Integrated in Groupe Bastide’s accounts from January 1, 2022, Saad
Perfusion will strengthen Bastide’s network on its domestic market
in a booming and profitable business segment.
The implementation of these acquisitions, aimed at rapidly
increasing profitability, reinforces the Group’s strategic vision
whereby digital is the cornerstone of the transformation of the
supply of medical devices and services, as is the strengthening of
domestic coverage in activities with high added value.
About Groupe Bastide Le Confort Médical
Created in 1977 by Guy Bastide, the BASTIDE group is a leading
European provider of home healthcare services. Present in 5
countries, BASTIDE develops a permanent quality approach and is
committed to providing medical devices and associated services that
best meet patients’ needs in key health areas: diabetes, nutrition,
perfusion, respiratory, stomatherapy and urology. BASTIDE is listed
on Euronext Paris (ISIN: FR0000035370, Reuters BATD.PA, - Bloomberg
BLC: FP).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220105005911/en/
Groupe Bastide Vincent Bastide Olivier Jourdanney T. +33
(0)4 66 38 68 08
NewCap Investor Relations Emmanuel Huynh T. +33
(0)1 44 71 20 42 bastide@newcap.eu
NewCap Press Relations Nicolas Merigeau T. +33
(0)1 44 71 94 98 bastide@newcap.eu
Bastide Le Confort Medical (EU:BLC)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Bastide Le Confort Medical (EU:BLC)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024